Clinical Trials Logo

Clinical Trial Summary

A number of prognostic and/or predictive genomic signatures for breast cancer have been developed by Genome Institute of Singapore (GIS). In the past 1 year, GIS has developed protocols and methods to conduct expression assays from formalin-fixed, paraffin-embedded (FFPE) tumor specimens. A study on 800 tumor samples is planned to analyze these gene signatures and compare them with conventional clinical prognosticators and predictors. As the investigators plan to use archival tumor samples that dates back to the 1990s, the aim of this pilot study is to first analyze 10 anonymized samples to determine the feasibility of running these assays on old archival blocks. The information generated will help us determine whether very old samples (diagnosed before 2000) may be selected for the actual study.


Clinical Trial Description

Up to 10 archival breast tumor blocks will be obtained from the Department of Pathology, NUH - half of these blocks will be from patients who were diagnosed before year 2000, and the other half of the blocks will be from patients diagnosed between year 2000-2005 (control specimens). Basic tumor and patient information will be collected without patient identifiers - grade, stage, ER/PR/HER2 status, treatment received, outcome data. 8-10 ten-micron sections will be cut from each tumor block. RNA will be extracted from the tumor sections using the Roche High Pure FFPE RNA Micro Kit. RNA will be profiled using the Illumina Veracode assay and the Affymetrix Quantigene assay. RNA extraction and gene expression profiling will be performed by collabroators at the Genome Institute of Singapore. ;


Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT01247467
Study type Observational
Source National University Hospital, Singapore
Contact
Status Active, not recruiting
Phase N/A
Start date August 2010
Completion date December 2014

See also
  Status Clinical Trial Phase
Recruiting NCT05544123 - The Treatment Situation of Chinese County Population With Breast Cancer
Completed NCT01881230 - Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) Phase 2/Phase 3
Withdrawn NCT05191004 - Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC Phase 1/Phase 2
Active, not recruiting NCT01247480 - Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin-embedded Tumor Specimens in Breast Cancer N/A
Recruiting NCT04626986 - Comparison of Microwave Ablation With Breast Conserving Surgery for Breast Tumor N/A
Completed NCT04805775 - Desflurane and Postoperative Sleep Quality in Patients Undergoing Elective Breast Surgery N/A
Recruiting NCT03347864 - 68Ga-NOTA-RM26 PET/CT in Breast Tumor Patients Early Phase 1
Completed NCT03684408 - Radiofrequency Chip for Localization of Non-Palpable Breast Lesions N/A
Recruiting NCT04692818 - 3D Ultrasound Breast Imaging N/A
Not yet recruiting NCT04825444 - Clinical Study of Vascular Imaging Evaluation of Computed Tomography Photoacoustic Breast Imaging System
Recruiting NCT05252390 - NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors Phase 1/Phase 2
Withdrawn NCT02470819 - Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer N/A
Completed NCT00859261 - Two Dimensional (2D) Silicon Transducer-Compression Plates for Breast Ultrasound N/A
Active, not recruiting NCT05169437 - Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors Phase 2
Recruiting NCT03870620 - Metastatic Breast Cancer in Austria
Completed NCT05185752 - Comparative Analysis of Three Locoregional Anesthesia Methods in Breast Tumour Pathology Surgery N/A
Recruiting NCT04852926 - Study of the Sexual Health of Patients Treated for Breast Cancer and Followed up in the Observatory of Fertility at Jeanne de Flandre Hospital.
Recruiting NCT06172270 - Sub-regional Tumor Segmentation Based on CEUS Perfusion Characteristics: Enhancing Breast Tumor Diagnosis
Recruiting NCT04948983 - The Effect of a Patient Decision Aids for Breast Cancer Screening N/A
Not yet recruiting NCT06251544 - TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer Phase 1